Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

PILL vs. LABU: which is better?

Bottom line

PILL vs LABU: the short answer

PILL (Direxion Daily Pharmaceutical & Medical Bull 3X ETF) and LABU (Direxion Daily S&P Biotech Bull 3X ETF) are both etfs.

But LABU is far broader, holding 163 positions to 73 for PILL, so beyond the top names it adds exposure PILL doesn't have.

LABU is cheaper at 0.96% vs 0.98% — a difference of $2.00 a year per $10,000 invested.

Over five years, PILL returned −12.6% a year vs −39.6% for LABU.

Updated Nov 19, 2026

PILL vs LABU side by side

PILLLABU
TypeETFETF
Fund familyDirexionDirexion
CategoryLeveraged & InverseLeveraged & Inverse
Expense ratio0.98%0.96%
Annual cost per $10k$98$96
10-yr cost on $10k (prospectus)$1,456$1,178
Max front loadNoneNone
12b-1 fee0%0%
1-yr return+75.0%+78.7%
5-yr return (annualized)−12.6%−39.6%
10-yr return (annualized)—−20.8%
Best quarter+103.7%+161.5%
Worst quarter−61.4%−67.4%
Net assets (fund)$20.7M$494.4M
Number of holdings73163
Portfolio turnover88%107%
Returns as ofDec 31, 2025Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Year-by-year returns

YearPILLLABUDifference
2025+75.0%+78.7%−3.7%
2024−6.9%−25.9%+19.0%
2023−12.7%−13.4%+0.8%
2022−43.1%−80.3%+37.2%
2021−37.2%−64.3%+27.1%
2020−0.3%+74.7%−75.0%
2019+18.2%+74.6%−56.5%
2018−19.6%−57.3%+37.7%

Source: Fund prospectus bar charts

Holdings overlap

5 of PILL's top 25 holdings also appear in LABU's top 25.

Shared top holdings
HoldingPILLLABU
Goldman Financial22.36%14.83%
N/a16.36%3.87%
Dreyfus8.14%15.86%
N/a7.41%3.87%
Goldman Sachs Liq Es Fd A2.03%5.35%

Source: SEC Form N-PORT

PILL top 10

  1. Goldman Financial — 22.36%
  2. N/a — 16.36%
  3. Dreyfus — 8.14%
  4. N/a — 7.41%
  5. Crinetics Pharmaceuticals In — 2.77%
  6. Mbx Biosciences Inc — 2.42%
  7. Ataibeckley Inc — 2.16%
  8. Definium Therapeutics, Inc — 2.13%
  9. Goldman Sachs Liq Es Fd A — 2.03%
  10. Amylyx Pharmaceuticals Inc — 1.72%

LABU top 10

  1. Dreyfus — 15.86%
  2. Goldman Financial — 14.83%
  3. N/a — 9.63%
  4. N/a — 7.30%
  5. Goldman Sachs Liq Es Fd A — 5.35%
  6. N/a — 4.85%
  7. N/a — 3.87%
  8. Apogee Therapeutics Inc — 1.11%
  9. Oruka Therapeutics Inc — 1.03%
  10. Dianthus Therapeutics Inc — 0.96%

FAQ

What is the difference between PILL and LABU?
PILL (Direxion Daily Pharmaceutical & Medical Bull 3X ETF) and LABU (Direxion Daily S&P Biotech Bull 3X ETF) are both etfs. But LABU is far broader, holding 163 positions to 73 for PILL, so beyond the top names it adds exposure PILL doesn't have.
Which is cheaper, PILL or LABU?
LABU has the lower expense ratio (0.96%).
Should I own both PILL and LABU?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.